- Home
- PRCT
as 11-21-2024 11:38am EST
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | SAN JOSE |
| Market Cap: | 5.3B | IPO Year: | 2021 |
| Target Price: | $89.50 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.95 | EPS Growth: | N/A |
| 52 Week Low/High: | $33.45 - $103.81 | Next Earning Date: | 10-28-2024 |
| Revenue: | $199,843,000 | Revenue Growth: | 71.71% |
| Revenue Growth (this year): | 67.06% | Revenue Growth (next year): | 40.59% |
Stock Insider Trading Activity of PROCEPT BioRobotics Corporation (PRCT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Zadno Reza | PRCT | President, CEO | Nov 13 '24 | Sell | $94.23 | 26,420 | $2,485,572.71 | 236,535 | |
| Desai Antal Rohit | PRCT | Director | Nov 5 '24 | Sell | $96.58 | 100,000 | $9,633,437.76 | 202,132 | |
| Zadno Reza | PRCT | President, CEO | Oct 30 '24 | Sell | $91.00 | 288,461 | $26,249,951.00 | 236,535 | |
| Waters Kevin | PRCT | EVP, CFO | Oct 15 '24 | Sell | $72.96 | 25,000 | $1,811,653.29 | 96,096 | |
| Waters Kevin | PRCT | EVP, CFO | Sep 16 '24 | Sell | $82.67 | 25,000 | $2,062,679.21 | 96,096 | |
| Desai Antal Rohit | PRCT | Director | Sep 10 '24 | Sell | $77.95 | 120,065 | $9,375,594.85 | 202,132 |
Latest PROCEPT BioRobotics Corporation News
PRCT Breaking Stock News: Dive into PRCT Ticker-Specific Updates for Smart Investing
MT Newswires
6 days ago
Procept Biorobotics Insider Sold Shares Worth $2,485,573, According to a Recent SEC Filing
MT Newswires
7 days ago
Procept BioRobotics Shares Decline After Jefferies Initiates Coverage at Hold
Zacks
14 days ago
Are You Looking for a Top Momentum Pick? Why PROCEPT BioRobotics Corporation (PRCT) is a Great Choice
Investor's Business Daily
20 days ago
These IBD 50 Leaders Melt Gains As Stock Market Wavers
MT Newswires
21 days ago
Procept BioRobotics Insider Sold Shares Worth $26,249,951, According to a Recent SEC Filing
MT Newswires
22 days ago
PROCEPT BioRobotics Prices $175 Million Offering by Selling Stockholder
GlobeNewswire
23 days ago
PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock
Zacks
23 days ago
All You Need to Know About PROCEPT BioRobotics (PRCT) Rating Upgrade to Strong Buy
Compare PRCT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRCT PROCEPT BioRobotics Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.